You are here

Media Resources

$10 Million Funding from Genome BC, BC Cancer Foundation, Genome Canada and CIHR spur Innovative Steps Toward New Cost-Effective Model to Diagnose and Treat Lymphoid Cancer in BC

 

DOWNLOAD VIDEO (Vimeo)
 

DOWNLOAD PHOTO 1

Caption: [left to right] Drs. Marco Marra, Joe Connors and Randy Gascoyne receive $10 million investment to develop a new model of cancer for lymphoid cancer diagnosis and treatment
 

DOWNLOAD PHOTO 2

Caption: [left to right] BC Cancer Agency’s Drs. Marco Marra, Joe Connors and Randy Gascoyne receive $10 million investment to develop a new model of cancer for lymphoid cancer diagnosis and treatment
 

DOWNLOAD PHOTO 3

Caption: [left to right] BC Cancer Agency’s Drs. Marco Marra, Joe Connors and Randy Gascoyne receive $10 million investment to develop a new model of cancer for lymphoid cancer diagnosis and treatment
 

DOWNLOAD PHOTO 4
Caption: [left to right] Drs. Joe Connors and Randy Gascoyne co-lead the BC Cancer Agency’s Centre for Lymphoid Cancers where they will utilize a new $10 million investment to develop a new model of cancer for lymphoid cancer diagnosis and treatment

 

First-in-Canada technology enables BC Cancer Agency specialists to better detect lung cancer - Accuracy improved by up to 80 per cent

DOWNLOAD VIDEO (Vimeo)

DOWNLOAD PHOTO 1
Caption: Dr. Annette McWilliams performs an bronchoscopy procedure with the LungPoint

DOWNLOAD PHOTO 2
Caption: Dr. Annette McWilliams is guided to a patient’s lung tumour with the new LungPoint

DOWNLOAD PHOTO 3
Caption: Dr. Stephen Lam & Dr. Annette McWilliams map out a patient’s bronchoscopy with the new BC Cancer Foundation funded LungPoint

DOWNLOAD PHOTO 4
Caption: BC Cancer Foundation donors provide $600,000 to acquire the new state-of-the-art LungPoint technology

For more information please contact:
Monica Bisal, Communications Specialist
Direct: 604-707-5934
Cell: 604-802-6984
Email: monica.bisal@bccancer.bc.ca